Related Experiment Video
Updated: Mar 7, 2026
07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
1.3K
Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: a
Ibironke W Apata1, John Hanfelt2, James L Bailey1
1Emory University School of Medicine, Atlanta, Georgia - USA.
The Journal of Vascular Access
|February 7, 2017
Summary
Replacing gauze with chlorhexidine-impregnated transparent (CHG-transparent) dressings significantly reduced catheter-related infection (CRI) rates in hemodialysis patients with central venous catheters (CVCs). This quality improvement project highlights CHG-transparent dressings as a key intervention for improving patient safety.
Area of Science:
- Nephrology
- Infectious Diseases
- Quality Improvement
Background:
- Central venous catheters (CVCs) used for hemodialysis are linked to higher infection risks compared to other vascular access methods.
- Chlorhexidine-impregnated transparent (CHG-transparent) dressings offer continuous antimicrobial action and site visibility, potentially reducing infections.
- Catheter-related infections (CRIs) pose significant risks, including increased morbidity and mortality in hemodialysis patients.
Purpose of the Study:
- To evaluate the impact of switching from adhesive dry gauze to CHG-transparent dressings on CRI rates in hemodialysis patients with tunneled CVCs.
- To compare the effectiveness of CHG-transparent dressings versus traditional gauze dressings in a real-world clinical setting.
Main Methods:
- A two-phase quality improvement project was implemented across three hemodialysis units.
- Phase 1: CHG-transparent dressings were introduced at one unit (EDC), while two units (EDG, EDN) continued with gauze.
- Phase 2: CHG-transparent dressings were adopted by the remaining two units (EDG, EDN), with EDC continuing CHG-transparent use. CRI rates were compared pre- and post-intervention.
Main Results:
- In Phase 1, the intervention unit (EDC) saw a 52% decrease in CRI rates (p<0.05). Control units showed no significant change.
- In Phase 2, intervention units (EDG, EDN) experienced significant CRI rate reductions of 86% (p<0.05) and 53% (p<0.05), respectively.
- The control unit (EDC) in Phase 2 showed a non-significant 20% decrease in CRI rates (p=0.65).
Conclusions:
- Transitioning to CHG-transparent dressings for tunneled CVCs in hemodialysis patients is associated with a substantial decrease in catheter-related infection rates.
- CHG-transparent dressings represent an effective strategy for enhancing patient safety and reducing infectious complications in hemodialysis vascular access.
